Univeristy of Dundee
Dundee, Angus, DD1 9SY, United Kingdom
NCT Number: NCT02505282
Postural hypotension is common in older people, leading to falls, decline in function, and dependence. Available treatments have limited efficacy and tolerability; novel approaches to treatment are therefore needed. Decreased vascular health, stiffening of the arteries and consequent decreased vascular reactivity are thought to contribute to postural hypotension and are therefore therapeutic targets.
Recent trial evidence has suggested that vitamin K may exert beneficial effects on vascular health particularly in respect to inhibiting calcification. Calcification increases vascular stiffness, decreases compliance and thus decreases the ability of blood vessels to autoregulate blood pressure and flow - which could contribute to postural drops in blood pressure. Worsened vascular health could also impact adversely on baroceptor function, which is needed for blood pressure autoregulation and which is disrupted in patients with orthostatic hypotension.
Vitamin K intake is below recommended daily intake in 60% of adults in the UK. In animals, vitamin K supplementation may be able to reverse calcification of arteries, and in humans Vitamin K has been shown to arrest decline in carotid artery elasticity compared to placebo. High levels of circulating vitamin K were also associated with lower levels of CRP in the Framingham cohort, suggesting a possible role in the suppression of chronic inflammation that is known to accompany vascular disease. The recent ECKO study suggested that vitamin K may reduce falls and fractures; an intriguing question that follows on from this is whether this could be due to beneficial effects on vascular health and postural hypotension, leading to less dizziness and reduced falls.
This cross-sectional comparative study aims to find whether there is a difference in the vitamin K status of patients with postural hypotension compared to those without postural hypotension and whether differences in vitamin K status are associated with other markers of vascular function in patients with and without postural hypotension. This could potentially lead to new treatments for the condition for which there is currently little of proven benefit.
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Dundee, Angus, DD1 9SY, United Kingdom
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Vitamin K status indicated by desphospho-uncarboxylated matrix Gla protein level
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
Time frame: Day 1
Measure of endothelial function
Time frame: Day 1
Measure of arterial stiffness and reflectivity
Time frame: Day 1
Time frame: Day 1
Measure of arterial stiffness and refelctivity
University of Dundee
Other
Acronym: VITKOH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03482297
Autonomic Failure, Autonomic Nervous System Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT02429557
Autonomic Failure, Autonomic Nervous System Diseases
Nashville, Tennessee, United States
View Trial DetailsNCT06694688
Autonomic Nervous System Diseases, Cardiovascular Diseases
Paris, France
View Trial DetailsNCT03354234
Autonomic Nervous System Diseases, Cardiovascular Diseases
Warsaw, Poland
View Trial Details